151 related articles for article (PubMed ID: 35538276)
1. Strontium-89 chloride delivery for painful bone metastases in patients with a history of prior irradiation.
Saito AI; Inoue T; Kinoshita M; Kosaka T; Mitsuhashi T
Ir J Med Sci; 2023 Apr; 192(2):569-574. PubMed ID: 35538276
[TBL] [Abstract][Full Text] [Related]
2. Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study.
Saito AI; Hirai T; Inoue T; Hojo N; Kawai S; Kato Y; Ito K; Kato M; Ozawa Y; Shinjo H; Toda K; Yoshimura RI
Anticancer Res; 2023 Feb; 43(2):865-873. PubMed ID: 36697080
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
[TBL] [Abstract][Full Text] [Related]
4. Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases.
Zenda S; Nakagami Y; Toshima M; Arahira S; Kawashima M; Matsumoto Y; Kinoshita H; Satake M; Akimoto T
Int J Clin Oncol; 2014 Aug; 19(4):739-43. PubMed ID: 23877652
[TBL] [Abstract][Full Text] [Related]
5. Strontium chloride Sr 89 for treating pain from metastatic bone disease.
Nightengale B; Brune M; Blizzard SP; Ashley-Johnson M; Slan S
Am J Health Syst Pharm; 1995 Oct; 52(20):2189-95. PubMed ID: 8564588
[TBL] [Abstract][Full Text] [Related]
6. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
7. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract][Full Text] [Related]
8. Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases.
Hamouda WE; Roshdy W; Teema M
Gulf J Oncolog; 2007 Jan; 1(1):35-41. PubMed ID: 20084712
[TBL] [Abstract][Full Text] [Related]
9. Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases.
Baba K; Kaida H; Hattori C; Muraki K; Kugiyama T; Fujita H; Ishibashi M
Hell J Nucl Med; 2018; 21(1):15-23. PubMed ID: 29550842
[TBL] [Abstract][Full Text] [Related]
10. Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy.
Valeriani M; Scaringi C; Blasi L; Carnevale A; De Sanctis V; Bonome P; Bracci S; Marrone G; Minniti G; Enrici RM
Tumori; 2015; 101(3):318-22. PubMed ID: 25908049
[TBL] [Abstract][Full Text] [Related]
11. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
Kurosaka S; Satoh T; Chow E; Asano Y; Tabata K; Kimura M; Tsumura H; Matsumoto K; Ishiyama H; Inoue Y; Hayakawa K; Baba S
Ann Nucl Med; 2012 Jul; 26(6):485-91. PubMed ID: 22477263
[TBL] [Abstract][Full Text] [Related]
12. Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience.
Heianna J; Toita T; Endo W; Kasuya G; Ariga T; Hashimoto S; Maemoto H; Terui K; Miura N; Togashi A; Miyauchi T; Murayama S
Ann Nucl Med; 2015 Dec; 29(10):848-53. PubMed ID: 26266885
[TBL] [Abstract][Full Text] [Related]
13. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
[TBL] [Abstract][Full Text] [Related]
14. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
Bauman G; Charette M; Reid R; Sathya J
Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
[TBL] [Abstract][Full Text] [Related]
16. Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases.
Hirano Y; Nakamura N; Zenda S; Hojo H; Motegi A; Arahira S; Toshima M; Onozawa M; Akimoto T
Int J Clin Oncol; 2016 Jun; 21(3):609-14. PubMed ID: 26614088
[TBL] [Abstract][Full Text] [Related]
17. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for palliation of symptoms in incurable cancer.
Hoegler D
Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
[TBL] [Abstract][Full Text] [Related]
19. [Initial report of strontium-89 chloride treatment for painful osseous metastases at Sakai Municipal Hospital].
Ikeda H; Ichida W; Nakaseko Y; Kato R; Fujimoto M; Nakanishi K; Sugimoto M; Maeda M; Hashimoto T; Harada K
Gan To Kagaku Ryoho; 2012 Jan; 39(1):63-8. PubMed ID: 22241353
[TBL] [Abstract][Full Text] [Related]
20. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
